MedTrace Logo

Post-Market Study of the Ellipse PRECICE Intramedullary Limb Lengthening System

NCT01601301 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-02-05

No results posted yet for this study

Summary

The purpose of this study is to obtain post market performance and safety data of the Ellipse PRECICE Intramedullary Limb Lengthening System for subjects undergoing unilateral limb lengthening.

Conditions

  • Limb Length Discrepancy

Interventions

DEVICE

PRECICE System

Lenthening of either the tibia or femur with the PRECICE System.

Sponsors & Collaborators

  • Ellipse Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Stuart A Green, MD · University of California, Irvine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01601301 on ClinicalTrials.gov